Verrica Pharmaceuticals Inc (VRCA)
8.69
-0.46
(-5.03%)
USD |
NASDAQ |
May 20, 16:00
8.69
0.00 (0.00%)
After-Hours: 19:14
Verrica Pharmaceuticals Total Liabilities (Quarterly): 64.80M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 64.80M |
| December 31, 2023 | 61.83M |
| September 30, 2023 | 54.84M |
| June 30, 2023 | 6.801M |
| March 31, 2023 | 3.793M |
| December 31, 2022 | 4.688M |
| September 30, 2022 | 4.382M |
| June 30, 2022 | 47.10M |
| March 31, 2022 | 46.20M |
| December 31, 2021 | 47.52M |
| September 30, 2021 | 47.90M |
| June 30, 2021 | 46.87M |
| March 31, 2021 | 46.29M |
| Date | Value |
|---|---|
| December 31, 2020 | 41.17M |
| September 30, 2020 | 40.75M |
| June 30, 2020 | 38.77M |
| March 31, 2020 | 37.83M |
| December 31, 2019 | 3.409M |
| September 30, 2019 | 4.421M |
| June 30, 2019 | 4.405M |
| March 31, 2019 | 3.218M |
| December 31, 2018 | 2.477M |
| September 30, 2018 | 2.451M |
| June 30, 2018 | 3.125M |
| March 31, 2018 | 1.648M |
| December 31, 2017 | 16.12M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.409M
Minimum
Dec 2019
64.80M
Maximum
Mar 2024
32.69M
Average
40.96M
Median
Total Liabilities (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 1.140B |
| Macrogenics Inc | 142.13M |
| Aquestive Therapeutics Inc | 165.82M |
| Recursion Pharmaceuticals Inc | 156.70M |
| Omega Therapeutics Inc | 142.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 66.31M |
| Shareholders Equity (Quarterly) | 1.508M |
| Debt to Equity Ratio | 28.41 |
| Current Ratio | 3.169 |
| Net Debt Paydown Yield | -3.41% |